Chemical Diversity of Locked Nucleic Acid-Modified Antisense Oligonucleotides Allows Optimization of Pharmaceutical Properties

por Papargyri, Natalia, Pontoppidan, Malene, Andersen, Mikael R., Koch, Troels, Hagedorn, Peter H.
Publicado 2019

P1556: HYPER -FERRITINEMIA IN PEDIATRIC ONCOLOGY PATIENTS SECONDARY TO TREATMENT: DIAGNOSTIC APPROACH AND OUTCOME

por Grafakos, I., Papadakis, V., Antoniadi, K., Ampatzidou, M., Papargyri, S., Kelaidi, C., Tzotzola, V., Polychronopoulou, S.
Publicado 2022